Logo image of ASPI

ASP ISOTOPES INC (ASPI) Stock Fundamental Analysis

NASDAQ:ASPI - Nasdaq - US00218A1051 - Common Stock - Currency: USD

5.4  +0.12 (+2.27%)

After market: 5.41 +0.01 (+0.19%)

Fundamental Rating

3

Overall ASPI gets a fundamental rating of 3 out of 10. We evaluated ASPI against 85 industry peers in the Chemicals industry. The financial health of ASPI is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ASPI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ASPI has reported negative net income.
In the past year ASPI has reported a negative cash flow from operations.
ASPI Yearly Net Income VS EBIT VS OCF VS FCFASPI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

ASPI has a Return On Assets of -37.22%. This is amonst the worse of the industry: ASPI underperforms 91.76% of its industry peers.
ASPI has a Return On Equity of -73.31%. This is amonst the worse of the industry: ASPI underperforms 85.88% of its industry peers.
Industry RankSector Rank
ROA -37.22%
ROE -73.31%
ROIC N/A
ROA(3y)-45.32%
ROA(5y)N/A
ROE(3y)-74.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ASPI Yearly ROA, ROE, ROICASPI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

With a decent Gross Margin value of 38.60%, ASPI is doing good in the industry, outperforming 78.82% of the companies in the same industry.
ASPI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ASPI Yearly Profit, Operating, Gross MarginsASPI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

5

2. Health

2.1 Basic Checks

ASPI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ASPI has more shares outstanding
Compared to 1 year ago, ASPI has a worse debt to assets ratio.
ASPI Yearly Shares OutstandingASPI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M
ASPI Yearly Total Debt VS Total AssetsASPI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

ASPI has an Altman-Z score of 4.06. This indicates that ASPI is financially healthy and has little risk of bankruptcy at the moment.
ASPI's Altman-Z score of 4.06 is amongst the best of the industry. ASPI outperforms 89.41% of its industry peers.
A Debt/Equity ratio of 0.76 indicates that ASPI is somewhat dependend on debt financing.
The Debt to Equity ratio of ASPI (0.76) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Altman-Z 4.06
ROIC/WACCN/A
WACC8.61%
ASPI Yearly LT Debt VS Equity VS FCFASPI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 9.31 indicates that ASPI has no problem at all paying its short term obligations.
ASPI's Current ratio of 9.31 is amongst the best of the industry. ASPI outperforms 97.65% of its industry peers.
ASPI has a Quick Ratio of 9.31. This indicates that ASPI is financially healthy and has no problem in meeting its short term obligations.
ASPI has a better Quick ratio (9.31) than 97.65% of its industry peers.
Industry RankSector Rank
Current Ratio 9.31
Quick Ratio 9.31
ASPI Yearly Current Assets VS Current LiabilitesASPI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

ASPI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.23%.
ASPI shows a strong growth in Revenue. In the last year, the Revenue has grown by 857.11%.
EPS 1Y (TTM)-30.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.8%
Revenue 1Y (TTM)857.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%175.75%

3.2 Future

The Earnings Per Share is expected to grow by 26.69% on average over the next years. This is a very strong growth
ASPI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 109.96% yearly.
EPS Next Y71.93%
EPS Next 2Y44.49%
EPS Next 3Y32.97%
EPS Next 5Y26.69%
Revenue Next Year682.93%
Revenue Next 2Y288.81%
Revenue Next 3Y183.67%
Revenue Next 5Y109.96%

3.3 Evolution

ASPI Yearly Revenue VS EstimatesASPI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
ASPI Yearly EPS VS EstimatesASPI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ASPI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ASPI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASPI Price Earnings VS Forward Price EarningsASPI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASPI Per share dataASPI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

4.3 Compensation for Growth

ASPI's earnings are expected to grow with 32.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.49%
EPS Next 3Y32.97%

More info and screens

0

5. Dividend

5.1 Amount

ASPI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ASP ISOTOPES INC

NASDAQ:ASPI (5/1/2025, 8:45:43 PM)

After market: 5.41 +0.01 (+0.19%)

5.4

+0.12 (+2.27%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-31 2025-03-31/dmh
Earnings (Next)N/A N/A
Inst Owners44.73%
Inst Owner Change0.01%
Ins Owners18.58%
Ins Owner Change10.87%
Market Cap389.18M
Analysts82.5
Price Target6.63 (22.78%)
Short Float %33.17%
Short Ratio9.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-36.17%
Min EPS beat(2)-41.61%
Max EPS beat(2)-30.72%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.79%
Min Revenue beat(2)-3.12%
Max Revenue beat(2)-2.45%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-66.67%
EPS NQ rev (3m)-66.67%
EPS NY rev (1m)-6.67%
EPS NY rev (3m)-6.67%
Revenue NQ rev (1m)-74.51%
Revenue NQ rev (3m)-74.51%
Revenue NY rev (1m)-2.13%
Revenue NY rev (3m)-2.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 93.91
P/FCF N/A
P/OCF N/A
P/B 8.13
P/tB 8.7
EV/EBITDA N/A
EPS(TTM)-0.65
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0.06
BVpS0.66
TBVpS0.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.22%
ROE -73.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.6%
FCFM N/A
ROA(3y)-45.32%
ROA(5y)N/A
ROE(3y)-74.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2412.47%
Cap/Sales 274.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.31
Quick Ratio 9.31
Altman-Z 4.06
F-Score5
WACC8.61%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.8%
EPS Next Y71.93%
EPS Next 2Y44.49%
EPS Next 3Y32.97%
EPS Next 5Y26.69%
Revenue 1Y (TTM)857.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%175.75%
Revenue Next Year682.93%
Revenue Next 2Y288.81%
Revenue Next 3Y183.67%
Revenue Next 5Y109.96%
EBIT growth 1Y-64.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-262.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-208.47%
OCF growth 3YN/A
OCF growth 5YN/A